NCT04137640 2021-07-20Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant ChemotherapyShengjing HospitalPhase 4 Not yet recruiting152 enrolled